These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7586615

  • 1. Naloxone-induced ACTH release: mechanism of action in humans.
    Jackson RV, Grice JE, Hockings GI, Torpy DJ.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):423-4. PubMed ID: 7586615
    [No Abstract] [Full Text] [Related]

  • 2. Hypothalamo-pituitary-interrenal responses to opioid substances in the trout. I. Effects of morphine on the release in vitro of corticotrophin-releasing activity from the hypothalamus and corticotrophin from the pituitary gland.
    Bird DJ, Buckingham JC, Baker BI, Mukherjee S.
    Gen Comp Endocrinol; 1987 Oct; 68(1):33-9. PubMed ID: 2822526
    [Abstract] [Full Text] [Related]

  • 3. Influence of various steroids on the production in vitro of corticotrophin releasing hormone and corticotrophin [proceedings].
    Buckingham JC.
    J Endocrinol; 1979 Oct; 83(1):38P-39P. PubMed ID: 230275
    [No Abstract] [Full Text] [Related]

  • 4. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
    Tsagarakis S, Navarra P, Rees LH, Besser M, Grossman A, Navara P.
    Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
    [Abstract] [Full Text] [Related]

  • 5. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
    Nakagami Y, Suda T, Yajima F, Ushiyama T, Tomori N, Sumitomo T, Demura H, Shizume K.
    Brain Res; 1986 Oct 29; 386(1-2):232-6. PubMed ID: 3022879
    [Abstract] [Full Text] [Related]

  • 6. The regulation of ACTH secretion by IL-1.
    Lumpkin MD.
    Science; 1987 Oct 23; 238(4826):452-4. PubMed ID: 2821618
    [No Abstract] [Full Text] [Related]

  • 7. Dynamics of the formation and release of corticotrophin releasing activity by the rat hypothalamus in vitro.
    Gillham B, Beckford U, Insall RL, Skelly AM, Jones MT.
    J Endocrinol; 1981 Aug 23; 90(2):201-10. PubMed ID: 6267155
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional activity of the hypothalamo-pituitary complex in the rat after betamethasone treatment.
    Buckingham JC, Hodges JR.
    J Endocrinol; 1977 Aug 23; 74(2):297-302. PubMed ID: 197190
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Participation of histamine in activating the hypothalamo-hypophyseo-adrenal system during stress].
    El'skiĭ VN.
    Fiziol Zh SSSR Im I M Sechenova; 1976 Sep 23; 62(9):1386-9. PubMed ID: 188693
    [Abstract] [Full Text] [Related]

  • 13. Release of amino-acids and neurosecretory substances after stimulation of nerve-endings (synaptosomes) isolated from the hypothalamus.
    Edwardson JA, Bennett GW, Bradford HF.
    Nature; 1972 Dec 29; 240(5383):554-6. PubMed ID: 4346709
    [No Abstract] [Full Text] [Related]

  • 14. Lipocortin 1 and hypothalamo-pituitary function in the rat.
    Taylor AD, Loxley HD, Flower RJ, Buckingham JC.
    Ann N Y Acad Sci; 1994 Nov 30; 746():441-5. PubMed ID: 7529974
    [No Abstract] [Full Text] [Related]

  • 15. CXCL10/CXCR3 signaling mediates inhibitory action by interferon-gamma on CRF-stimulated adrenocorticotropic hormone (ACTH) release.
    Horiguchi K, Fujiwara K, Tsukada T, Yoshida S, Higuchi M, Tateno K, Hasegawa R, Takigami S, Ohsako S, Yashiro T, Kato T, Kato Y.
    Cell Tissue Res; 2016 May 30; 364(2):395-404. PubMed ID: 26572542
    [Abstract] [Full Text] [Related]

  • 16. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls.
    Michelson D, Altemus M, Galliven E, Hill L, Greenberg BD, Gold P.
    Neuropsychopharmacology; 1996 Aug 30; 15(2):207-12. PubMed ID: 8840357
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat.
    Buckingham JC.
    Eur J Pharmacol; 1984 Feb 17; 98(2):211-21. PubMed ID: 6325216
    [Abstract] [Full Text] [Related]

  • 18. Effects on ACTH release, of intrapituitary injections of posterior pituitary hormones and several amines in the hypothalamus.
    Hiroshige T, Kunita H, Ogura C, Itoh S.
    Jpn J Physiol; 1968 Oct 15; 18(5):609-19. PubMed ID: 4303323
    [No Abstract] [Full Text] [Related]

  • 19. From neurosecretion to neural communication and beyond. The 26th annual Robert Wartenberg lecture.
    Zimmerman EA.
    Neurology; 1986 Jun 15; 36(6):809-14. PubMed ID: 3010182
    [No Abstract] [Full Text] [Related]

  • 20. Dynorphin stimulates corticotropin release from mouse anterior pituitary AtT-20 cells through nonopioid mechanisms.
    Cheng PY, Birk AV, Gershengorn MC, Szeto HH.
    Neuroendocrinology; 2000 Mar 15; 71(3):170-6. PubMed ID: 10729788
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.